FDA Approved Products

4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
Active:Lifecycle: LOE ApproachingClear all
EXNA
benzthiazide
LOE Approaching
ORAL · TABLET
1960
NDA
30/100
EXOSURF NEONATAL
cetyl alcohol; colfosceril palmitate; tyloxapol
LOE Approaching
GSK
INTRATRACHEAL · FOR SUSPENSION
1990
NDA
30/100
EXTINA
ketoconazole
LOE Approaching
TOPICAL · AEROSOL, FOAM
2007
SMNDA
30/100
EXTRA-STRENGTH AIM
sodium monofluorophosphate
LOE Approaching
DENTAL · GEL
1986
NDA
30/100
EXTRANEAL
icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
LOE Approaching
Vantive
INTRAPERITONEAL · SOLUTION
(compared to 4
2002
NDA
30/100
FACTIVE
gemifloxacin mesylate
LOE Approaching
LG Chem Life Sciences
ORAL · TABLET
infections caused by susceptible strains of the designated microorganisms in the conditions listed belowdevelopment of drug-resistant bacteria+4
2003
NDA
30/100
FACTREL
gonadorelin hydrochloride
LOE Approaching
Hikma
INJECTION · INJECTABLE
1982
NDA
30/100
FAMVIR
famciclovir
LOE Approaching
Novartis
ORAL · TABLET
recurrent herpes labialis in adult patientsrecurrent episodes of genital herpes+3
1994
SMNDA
30/100
FANSIDAR
pyrimethamine; sulfadoxine
LOE Approaching
Roche
ORAL · TABLET
toxoplasmosissince synergism exists with this combination
1981
NDA
30/100
FARESTON
toremifene citrate
LOE Approaching
Kyowa Hakko Kirin
ORAL · TABLET
metastatic breast cancer in postmenopausal women with estrogen-receptor positiveunknown tumors+1
1997
NDA
30/100
FASLODEX
fulvestrant
LOE Approaching
AstraZeneca
INTRAMUSCULAR · SOLUTION
breast cancer
2002
NDA
30/100
FASTIN
phentermine hydrochloride
LOE Approaching
GSK
ORAL · CAPSULE
hypertension
1973
NDA
30/100
FAZACLO ODT
clozapine
LOE Approaching
Jazz Pharmaceuticals
ORAL · TABLET, ORALLY DISINTEGRATING
severely ill patients with schizophreniaschizophrenia
2004
NDA
30/100
FELBATOL
felbamate
LOE Approaching
Viatris (2)
ORAL · SUSPENSION
epilepsyanemia
1993
NDA
30/100
FELDENE
piroxicam
LOE Approaching
Pfizer
ORAL · CAPSULE
rheumatoid arthritis
1982
NDA
30/100
FEMARA
letrozole
LOE Approaching
Novartis
ORAL · TABLET
breast cancer
1997
SMNDA
30/100
FEMCON FE
ethinyl estradiol; norethindrone
LOE Approaching
ORAL · TABLET
pregnancy in women
2003
NDA
30/100
FEMHRT
ethinyl estradiol; norethindrone acetate
LOE Approaching
ORAL · TABLET
women with an intact uterus for the: Treatment of moderate to severe vasomotor symptoms associated with the menopauseosteoporosis
1999
NDA
30/100
FEMHRT
ethinyl estradiol; norethindrone acetate
LOE Approaching
AbbVie
ORAL · TABLET
women with an intact uterus for the: Treatment of moderate to severe vasomotor symptoms associated with the menopauseosteoporosis
1999
NDA
30/100
FEMPATCH
estradiol
LOE Approaching
Pfizer
TRANSDERMAL · FILM, EXTENDED RELEASE
moderate to severe vasomotor symptoms due to menopause ()
1996
NDA
30/100
FEMRING
estradiol acetate
LOE Approaching
Millicent Pharma
VAGINAL · INSERT, EXTENDED RELEASE
Moderate to Severe Vasomotor Symptoms due to Menopause ()Moderate to Severe Vulvar+1
2003
NDA
30/100
FEMSTAT 3
butoconazole nitrate
LOE Approaching
Bayer
VAGINAL · CREAM
1995
NDA
30/100
FEMTRACE
estradiol acetate
LOE Approaching
ORAL · TABLET
pregnancy in women
2004
NDA
30/100
FENOGLIDE
fenofibrate
LOE Approaching
Salix Pharmaceuticals
ORAL · TABLET
2007
NDA
30/100
← PreviousPage 62 of 188Next →